Matches in DBpedia 2016-04 for { ?s ?p "Susan Desmond-Hellmann, MD, MPH, is the Chief Executive Officer of the Bill & Melinda Gates Foundation (BMGF).On December 17, 2013 The Bill & Melinda Gates Foundation announced that it had selected Susan Desmond-Hellmann, M.D., M.P.H., as its next chief executive officer. Desmond-Hellmann assumed her role on May 1, 2014.She was previously UCSF chancellor, appointed by UC President Mark Yudof on May 7, 2009, and held the post from August 3, 2009 to March 2014. She became the first woman chancellor of the nearly 150-year-old university. While chancellor, Desmond-Hellmann, an oncologist and biotechnology leader, held the Arthur and Toni Rembe Rock Distinguished Professorship at UCSF and oversaw all aspects of the university and medical center’s strategy and operations.Before that she was president of product development at Genentech (March 2004 through April 30, 2009), where she was credited for her role in the development of two of the first gene-targeted therapies for cancer, Avastin and Herceptin. Desmond-Hellmann also served as a member of Genentech’s executive committee, beginning in 1996.Desmond-Hellmann is a recognized leader on issues of higher education, public health, drug development, regulatory innovation and health policy."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Susan_Desmond-Hellmann abstract "Susan Desmond-Hellmann, MD, MPH, is the Chief Executive Officer of the Bill & Melinda Gates Foundation (BMGF).On December 17, 2013 The Bill & Melinda Gates Foundation announced that it had selected Susan Desmond-Hellmann, M.D., M.P.H., as its next chief executive officer. Desmond-Hellmann assumed her role on May 1, 2014.She was previously UCSF chancellor, appointed by UC President Mark Yudof on May 7, 2009, and held the post from August 3, 2009 to March 2014. She became the first woman chancellor of the nearly 150-year-old university. While chancellor, Desmond-Hellmann, an oncologist and biotechnology leader, held the Arthur and Toni Rembe Rock Distinguished Professorship at UCSF and oversaw all aspects of the university and medical center’s strategy and operations.Before that she was president of product development at Genentech (March 2004 through April 30, 2009), where she was credited for her role in the development of two of the first gene-targeted therapies for cancer, Avastin and Herceptin. Desmond-Hellmann also served as a member of Genentech’s executive committee, beginning in 1996.Desmond-Hellmann is a recognized leader on issues of higher education, public health, drug development, regulatory innovation and health policy.".
- Q7647750 abstract "Susan Desmond-Hellmann, MD, MPH, is the Chief Executive Officer of the Bill & Melinda Gates Foundation (BMGF).On December 17, 2013 The Bill & Melinda Gates Foundation announced that it had selected Susan Desmond-Hellmann, M.D., M.P.H., as its next chief executive officer. Desmond-Hellmann assumed her role on May 1, 2014.She was previously UCSF chancellor, appointed by UC President Mark Yudof on May 7, 2009, and held the post from August 3, 2009 to March 2014. She became the first woman chancellor of the nearly 150-year-old university. While chancellor, Desmond-Hellmann, an oncologist and biotechnology leader, held the Arthur and Toni Rembe Rock Distinguished Professorship at UCSF and oversaw all aspects of the university and medical center’s strategy and operations.Before that she was president of product development at Genentech (March 2004 through April 30, 2009), where she was credited for her role in the development of two of the first gene-targeted therapies for cancer, Avastin and Herceptin. Desmond-Hellmann also served as a member of Genentech’s executive committee, beginning in 1996.Desmond-Hellmann is a recognized leader on issues of higher education, public health, drug development, regulatory innovation and health policy.".